Chronic nephritic syndrome

N14_CHRONEPHROPATH

nephritis: Inflammation of renal tissue. [ NCIT:P378 ]

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N03# Hospital discharge: ICD-9 — 582 Hospital discharge: ICD-8 — 582 Cause of death: ICD-10 — N03# Cause of death: ICD-9 — 582 Cause of death: ICD-8 — 582 2 out of 7 registries used, show all original rules.	1493
4. Check minimum number of events None	1493
5. Include endpoints None	1493
6. Filter based on genotype QC (FinnGen only)	1493

Control definitions (FinnGen only)

Control exclude: N14_GLOMERULAR

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N00-N08
Name in latin: Syndroma nephriticum chronicum

NAME	N14_CHRONEPHROPATH
CONTROL_EXCLUDE	N14_GLOMERULAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N03
HD_ICD_9	582
HD_ICD_8	582
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N03
COD_ICD_9	582
COD_ICD_8	582
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Chronic nephritic syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11680	4699	6744
Only index persons	7799	3375	4424
Unadjusted period prevalence (%)
Whole population	0.17	0.13	0.19
Only index persons	0.15	0.12	0.17
Median age at first event (years)
Whole population	50.03	48.25	51.03
Only index persons	43.31	41.25	44.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1493	622	871
Unadjusted period prevalence (%)	0.31	0.21	0.38
Median age at first event (years)	43.32	37.52	47.46

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1360: Matched controls
13601

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

427.6

323.0

324

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

121.3

323.0

496

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

+∞

323.0

502

Z94.0

ICD-10 Finland

Kidney transplant status

226.2

323.0

365

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

25.5

323.0

487

291

A12AA04

ATC

calcium carbonate; oral

103.2

323.0

353

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

131.7

323.0

451

A11CC03

ATC

alfacalcidol; systemic

69.6

323.0

407

127

Kela drug reimbursment

Transplant complication

95.5

316.5

344

L04AA06

ATC

mycophenolic acid; systemic

73.1

298.2

337

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

+∞

295.9

273

N18.8

ICD-10 Finland

Other chronic renal failure

44.2

274.4

341

102

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

221.0

265.2

267

TK800

NOMESCO Finland

Hemodialysis

52.9

263.2

315

137

Kela drug reimbursment

Uraemia requiring dialysis

231.3

260.9

262

Z49.1

ICD-10 Finland

Extracorporeal dialysis

115.2

244.5

261

C03CA01

ATC

furosemide; systemic

7.2

237.6

806

2290

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

161.6

232.1

240

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

+∞

228.7

213

L04AD01

ATC

ciclosporin; systemic

38.4

219.9

282

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

220.7

219.5

222

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

+∞

213.3

199

N18.0

ICD-10 Finland

End-stage renal disease

145.5

210.5

220

205

Kela drug reimbursment

Chronic hypertension

6.3

209.4

778

2365

B03XA02

ATC

darbepoetin alfa; parenteral

50.7

207.1

250

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

185.3

199.9

205

58209

ICD-8 Finland

Chronic nephritis, Unspecified

+∞

197.8

185

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

77.3

196.5

221

B05DA

ATC

Isotonic solutions

248.0

190.8

192

L04AA01

ATC

[U] ciclosporin; systemic

49.9

186.7

226

H02AB04

ATC

methylprednisolone; systemic

7.2

180.6

518

1067

Z49.0

ICD-10 Finland

Preparatory care for dialysis

117.3

171.0

183

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

214.0

166.0

169

V03AE01

ATC

polystyrene sulfonate; oral

77.2

166.0

187

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

89.1

162.0

179

M04AA01

ATC

allopurinol; systemic

6.9

160.6

470

970

Z49.2

ICD-10 Finland

Other dialysis

205.4

159.6

163

R80

ICD-10 Finland

Isolated proteinuria

81.1

158.2

177

B05DB

ATC

Hypertonic solutions

202.6

157.5

161

B03XA01

ATC

erythropoietin; parenteral

125.8

156.1

166

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

+∞

150.9

142

C09AA02

ATC

enalapril; systemic

5.3

148.3

574

1645

N03.2

ICD-10 Finland

Chronic nephritic syndrome, diffuse membranous glomerulonephritis

+∞

137.9

130

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.0

137.1

444

1014

N03.0

ICD-10 Finland

Chronic nephritic syndrome, minor glomerular abnormality

+∞

133.6

126

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

+∞

129.2

122

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

+∞

129.2

122

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

9.4

128.7

286

373

KA1AE

NOMESCO Finland

Kidney ultrasound examination

19.6

126.0

196

116

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

9.0

125.5

287

392

196

Kela drug reimbursment

Paricalcitol and cinacalcet

227.0

121.9

124

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

+∞

119.6

113

V03AE02

ATC

sevelamer; oral

255.6

115.7

117

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

+∞

115.3

109

C08CA01

ATC

amlodipine; oral

3.8

114.8

723

3105

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

129.0

111.0

118

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

129.0

111.0

118

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

201.1

108.1

111

L04AX01

ATC

azathioprine; systemic

10.3

107.6

224

255

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

10.7

103.7

211

229

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

+∞

100.2

C02AC05

ATC

moxonidine; oral

10.4

99.3

205

228

H05BX01

ATC

cinacalcet; oral

77.1

94.9

107

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

149.0

92.3

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

30.6

91.3

123

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

160.4

86.2

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

+∞

85.3

TK820

NOMESCO Finland

Peritoneal dialysis

185.6

84.2

58200

ICD-8 Finland

Chronic nephritis, Cum uraemia

+∞

82.1

N04.2

ICD-10 Finland

Nephrotic syndrome, diffuse membranous glomerulonephritis

+∞

81.0

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

7.2

79.3

205

325

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

813.6

79.2

C08CA02

ATC

felodipine; oral

5.2

77.6

265

599

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

61.8

74.7

7151

FHL

Kidney transplantation

382.1

73.4

V03AE03

ATC

lanthanum carbonate; oral

260.5

73.1

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.0

72.1

562

2559

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

46.9

72.1

N19

ICD-10 Finland

Unspecified kidney failure

10.1

71.8

149

164

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.1

71.2

140

139

N03.5

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangiocapillary glomerulonephritis

+∞

69.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

68.0

738

4098

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

6.0

67.1

199

376

C07AG02

ATC

carvedilol; oral

6.1

67.1

198

372

5829A

ICD-9 Finland

Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]

+∞

66.2

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

145.2

65.5

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

669.0

65.5

C02EA02

ATC

7.0

64.7

170

273

M10.9

ICD-10 Finland

Gout, unspecified

5.3

63.9

211

453

321

Kela drug reimbursment

Paricalcitol and cinacalcet

47.9

63.4

C08CA13

ATC

lercanidipine; oral

3.9

61.4

291

892

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.2

55.6

237

656

C09CA01

ATC

losartan; oral

2.9

55.6

437

1927

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

198.1

55.4

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

121.0

54.2

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

548.8

53.9

C07AB02

ATC

metoprolol; systemic

3.0

53.8

385

1592

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

6.4

52.9

147

253

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

187.2

52.3

M01AE01

ATC

ibuprofen; systemic, rectal

0.4

52.1

780

10488

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.7

51.6

138

225

ZX120

NOMESCO Finland

Intravenous

4.0

51.3

229

658

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.8

51.1

244

743

C02CA01

ATC

prazosin; oral

13.3

50.5

58399

ICD-8 Finland

Nephritis, unqualified

+∞

50.3

C10AA05

ATC

atorvastatin; oral

2.4

50.0

612

3425

58199

ICD-8 Finland

Nephrotic syndrome

+∞

49.3

R50.9

ICD-10 Finland

Fever, unspecified

3.2

48.9

295

1073

R31

ICD-10 Finland

Unspecified haematuria

3.7

48.7

238

737

N05.9

ICD-10 Finland

Unspecified nephritic syndrome, unspecified

+∞

48.2

7910X

ICD-9 Finland

Nonspecific findings on examination of urine, Proteinuria[PROTEINURIA NUD]

132.3

48.1

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.9

48.0

222

655

M10.3

ICD-10 Finland

Gout due to impairment of renal function

78.8

47.3

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

86.5

45.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.9

45.1

202

578

ZXD05

NOMESCO Finland

Urgent procedure

2.4

45.1

530

2860

I10

ICD-10 Finland

Essential (primary) hypertension

2.2

43.4

838

5695

C10AA04

ATC

fluvastatin; oral

3.9

43.2

192

545

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

227.1

43.2

R4110

NOMESCO Finland

Physiotherapy

2.4

41.9

444

2254

U14

ICPC

Kidney symptom/complaint

14.1

41.1

K65.0

ICD-10 Finland

Acute peritonitis

14.8

40.8

WW200

NOMESCO Finland

Immunization

6.8

40.0

105

166

L01BB01

ATC

49.6

40.0

Z2446

NOMESCO Finland

Social worker

4.2

39.3

158

408

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.2

38.9

235

845

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.8

38.8

288

1187

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

+∞

38.7

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

+∞

38.7

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

38.0

452

2407

A41.9

ICD-10 Finland

Sepsis, unspecified

6.1

37.8

108

191

RD210

NOMESCO Finland

10.0

37.8

212

Kela drug reimbursment

Gout

8.1

37.6

114

3AC01

NOMESCO Finland

16.9

37.5

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

37.4

557

3286

ZXA00

NOMESCO Finland

Right side

2.3

37.3

434

2281

L04AA05

ATC

[U] tacrolimus; systemic

377.2

37.2

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.6

37.1

160

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

7.0

37.1

145

TK810

NOMESCO Finland

Hemofiltration

24.5

36.8

A12BA01

ATC

potassium chloride; oral

5.3

36.8

117

236

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

9.9

36.6

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

23.4

36.4

I15.0

ICD-10 Finland

Renovascular hypertension

61.8

36.3

L01AA01

ATC

cyclophosphamide; systemic

28.2

36.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.1

36.1

217

776

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

100.3

35.9

J01MA12

ATC

levofloxacin; systemic

2.5

35.8

331

1541

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

38.7

35.8

5820A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,EI NEFR SDR]

+∞

35.6

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

35.6

78930

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Haematuria

26.1

34.7

ZXE20

NOMESCO Finland

More than three and less than five hours

2.7

34.5

265

1109

B01AB10

ATC

tinzaparin; parenteral

3.8

34.2

158

460

C09CA06

ATC

candesartan; oral

2.4

34.2

343

1663

Z3226

NOMESCO Finland

Physiotherapist

2.5

34.0

310

1426

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

46.9

33.9

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

12.5

33.6

5839X

ICD-9 Finland

Nephritis and nephropathy, not specified as acute or chronic, With unspecified pathological lesion in kidney

+∞

33.5

5828B

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,NEFR SDR]

+∞

33.5

J01FF01

ATC

clindamycin; systemic

2.2

33.4

440

2427

Z3231

NOMESCO Finland

Registered nurse

2.2

32.9

435

2402

78900

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Albuminuria

31.7

32.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

32.1

281

1261

H05BX02

ATC

paricalcitol; systemic

324.2

32.0

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

31.7

352

1784

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.9

31.6

163

N06.9

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, unspecified

+∞

31.4

58099

ICD-8 Finland

Acute nephritis

+∞

31.4

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.8

31.3

139

391

N03.7

ICD-10 Finland

Chronic nephritic syndrome, diffuse crescentic glomerulonephritis

+∞

30.3

ZXA05

NOMESCO Finland

Left side

2.2

30.3

385

2074

H26.3

ICD-10 Finland

Drug-induced cataract

18.0

30.2

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.6

30.0

109

254

WX202

NOMESCO Finland

Supraclavicular plexus blockade

10.1

29.8

C08CA05

ATC

nifedipine; systemic

3.8

29.8

135

386

C02DE10

ATC

12.8

29.7

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

51.2

29.5

B07.9

ICD-10 Finland

Verruca simplex

5.2

28.9

190

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

298.0

28.9

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

81.9

28.9

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

81.9

28.9

RS220

NOMESCO Finland

10.0

28.3

A46

ICD-10 Finland

Erysipelas

2.6

28.3

242

1063

H02AB06

ATC

prednisolone; systemic

1.9

28.3

660

4499

5602

FHL

Internal fistula (eg Cimino)

+∞

28.2

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

28.0

424

2446

C08CA03

ATC

isradipine; systemic

8.9

27.9

XPX08

NOMESCO Finland

Intraoperative flow measurement

16.8

27.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.3

27.5

106

261

3025

Kela drug reimbursment

Calcium carbonate

54.5

27.3

KBV00

NOMESCO Finland

Insertion of stent into ureter

17.0

27.2

N00.9

ICD-10 Finland

Acute nephritic syndrome, Unspecified

+∞

27.2

N04.3

ICD-10 Finland

Nephrotic syndrome, diffuse mesangial proliferative glomerulonephritis

+∞

27.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

27.1

334

1758

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

19.2

27.1

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

98.7

26.7

5819X

ICD-9 Finland

Nephrotic syndrome with unspecified pathological lesion in kidney

+∞

26.1

R4190

NOMESCO Finland

Nutritional therapy

5.0

25.9

178

ZXE00

NOMESCO Finland

One hour or less

1.9

25.8

553

3615

C07AB07

ATC

bisoprolol; oral

1.9

25.8

651

4507

J01MA02

ATC

ciprofloxacin; systemic

1.9

25.8

567

3741

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

265.4

25.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

25.7

366

2043

WW500

NOMESCO Finland

Blood transfusion

4.5

25.4

223

N02AX02

ATC

tramadol; systemic, rectal

1.9

25.4

606

4110

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.9

25.3

164

610

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

25.3

147

506

WX610

NOMESCO Finland

Patient controlled analgesia

23.1

25.3

4019X

ICD-9 Finland

Essential hypertension, Unspecified

5.9

25.2

128

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

13.8

25.1

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

+∞

25.1

N00.2

ICD-10 Finland

Acute nephritic syndrome, Diffuse membranous glomerulonephritis

+∞

25.1

N03.4

ICD-10 Finland

Chronic nephritic syndrome, diffuse endocapillary proliferative glomerulonephritis

+∞

25.1

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.2

24.9

136

450

M05BA04

ATC

alendronic acid; oral

3.2

24.8

139

467

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

91.8

24.7

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

132.4

24.7

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.1

24.2

139

476

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

24.0

187

Kela drug reimbursment

MPA

+∞

24.0

5850B

ICD-9 Finland

Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]

+∞

24.0

N082, D898

ICD-10 Finland

+∞

24.0

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

13.6

23.8

BBA50

NOMESCO Finland

Total parathyroidectomy

127.2

23.7

K65.8

ICD-10 Finland

Other peritonitis

47.6

23.4

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

5.5

23.4

132

C10AA01

ATC

simvastatin; oral

1.8

23.2

596

4099

40399

ICD-8 Finland

Hypertensive renal disease

37.0

23.0

N25.0

ICD-10 Finland

Renal osteodystrophy

40.8

22.7

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.6

22.7

108

321

JAL10

NOMESCO Finland

Laparotomy and removal of foreign body

233.7

22.7

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

13.9

22.3

N18

ICD-10 Finland

Chronic kidney disease

17.1

22.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

22.1

184

791

K06.18

ICD-10 Finland

Another gingival hyperplasia

35.7

22.1

M10.0

ICD-10 Finland

Idiopathic gout

4.3

22.0

201

N04.89

ICD-10 Finland

Nephrotic syndrome, other

+∞

21.9

N04.5

ICD-10 Finland

Nephrotic syndrome, diffuse mesangiocapillary glomerulonephritis

+∞

21.9

N00.0

ICD-10 Finland

Acute nephritic syndrome, Minor glomerular abnormality

+∞

21.9

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

21.8

272

1425

UKC02

NOMESCO Finland

Cystoscopy

2.2

21.4

256

1315

RJ411

NOMESCO Finland

19.2

21.3

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

50.8

21.2

A02BC01

ATC

omeprazole; systemic

1.9

21.0

394

2417

6119

FHL

Other measure in this category

+∞

20.9

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.2

20.7

114

379

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

111.7

20.6

U88

ICPC

Glomerulonephritis/nephrosis

111.7

20.6

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

111.7

20.6

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

25.9

20.5

C08DB01

ATC

diltiazem; oral

3.5

20.3

300

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

33.1

20.2

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.9

20.1

229

L57.0

ICD-10 Finland

Actinic keratosis

2.7

20.0

146

580

J01MA14

ATC

moxifloxacin; systemic

2.6

20.0

153

627

5829B

ICD-9 Finland

Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,NEFR SDR]

+∞

19.8

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

19.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

19.8

543

3754

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.9

19.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

19.7

143

568

B01AA03

ATC

warfarin; systemic

2.0

19.6

300

1700

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.5

19.6

276

K65.9

ICD-10 Finland

Peritonitis, unspecified

31.8

19.3

WX203

NOMESCO Finland

Infraclavicular plexus blockade

5.3

19.2

115

5997A

ICD-9 Finland

Other disorders of urethra and urinary tract, Haematuria

17.0

19.2

WX002

NOMESCO Finland

Sedation and analgesia

2.0

19.1

277

1533

N06.1

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, focal and segmental glomerular lesions

+∞

18.8

5821B

ICD-9 Finland

Chronic glomerulonephritis, With lesion of membranous glomerulonephritis[GLOMERULONEPHRITIS CHRONICA MEMBRANACEA,NEFR SDR]

+∞

18.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

18.7

171

769

ZXC50

NOMESCO Finland

Cryotherapy

4.7

18.7

145

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

18.6

216

1088

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

18.6

192

918

Z99.2

ICD-10 Finland

Dependence on renal dialysis

101.4

18.6

KAS40

NOMESCO Finland

Excision of transplanted kidney

192.5

18.6

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

9.7

18.4

A02BC02

ATC

pantoprazole; systemic

1.7

18.4

848

6757

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.2

18.2

173

C02DE02

ATC

6.2

18.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.3

17.9

162

Z2221

NOMESCO Finland

Medical doctor

1.8

17.5

378

2404

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

8.5

17.5

N17.8

ICD-10 Finland

Other acute renal failure

9.2

17.4

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

17.4

353

2200

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

42.6

17.3

5AB14

NOMESCO Finland

42.6

17.3

J01DA01

ATC

[U] cefalexin; systemic

1.6

17.3

822

6545

ZX108

NOMESCO Finland

Inhalation

9.9

17.2

M13.9

ICD-10 Finland

Arthritis, unspecified

2.7

16.8

118

460

5821A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of membranous glomerulonephritis[GLOMERULONEPHRITIS CHRONICA MEMBRANACEA,EI NEFR SDR]

+∞

16.7

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

+∞

16.7

B04AB02

ATC

5.1

16.5

105

KBV10

NOMESCO Finland

Removal of stent from ureter

10.2

16.5

M31.3

ICD-10 Finland

Wegener granulomatosis

20.3

16.4

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

6.2

16.4

WX204

NOMESCO Finland

Axillary plexus blockaced

3.9

16.3

177

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

15.6

16.2

M01AH05

ATC

etoricoxib; oral

0.6

16.2

429

5864

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

16.1

210

WW400

NOMESCO Finland

Plasmaferesis

48.1

16.0

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

13.7

16.0

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.6

15.9

119

480

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.0

15.8

334

M10

ICD-10 Finland

Gout

3.2

15.8

279

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

15.7

156

729

9968A

ICD-9 Finland

Complications peculiar to certain specified procedures, Complications of transplanted organ

+∞

15.6

N08.2*D69.0

ICD-10 Finland

Glomerular disorders in Henoch(-Schönlein) purpura

+∞

15.6

N08.2*D89.82

ICD-10 Finland

Nepropathy caused by deposition of the light chain of the immunoglobulins

+∞

15.6

J01DB01

ATC

cefalexin; oral

1.7

15.6

1064

9208

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.5

15.4

128

547

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.3

15.3

151

704

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

15.2

495

3524

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

18.0

15.2

C09BA02

ATC

enalapril and diuretics; systemic

2.4

15.1

130

566

E87.5

ICD-10 Finland

Hyperkalaemia

5.7

15.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.1

14.9

146

J01CA04

ATC

amoxicillin; systemic

1.7

14.8

1033

8904

UJF32

NOMESCO Finland

Coloscopy

1.7

14.8

337

2163

H02AB07

ATC

prednisone; oral

2.0

14.8

199

1062

Z3229

NOMESCO Finland

Other healthcare associate professional

2.4

14.8

131

581

WX402

NOMESCO Finland

General anaesthesia

1.9

14.8

225

1262

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.6

14.7

188

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

14.7

110

446

N06.2

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, diffuse membranous glomerulonephritis

+∞

14.6

N02.9

ICD-10 Finland

Recurrent and persistent haematuria, unspecified

+∞

14.6

N06.3

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, diffuse mesangial proliferative glomerulonephritis

+∞

14.6

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

81.0

14.6

5900A

ICD-9 Finland

Infections of kidney, Chronic pyelonephritis

81.0

14.6

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

12.7

14.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.4

14.3

123

D69.0

ICD-10 Finland

Allergic purpura

10.6

14.2

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

22.5

14.2

306

Kela drug reimbursment

Erythropoietin and darbepoetin

22.5

14.2

C09AA01

ATC

captopril; oral

5.0

13.9

204

Kela drug reimbursment

Leukemia lymphatica

3.7

13.9

166

5604

FHL

Vascular preparation or cannulation in the operating room

30.4

13.9

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

53.9

13.8

RJ421

NOMESCO Finland

20.3

13.8

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.3

13.7

119

D638, N188

ICD-10 Finland

75.9

13.6

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

+∞

13.6

N03

ICD-10 Finland

Chronic nephritic syndrome

+∞

13.6

7155

FHL

Exploration of the graft

+∞

13.6

5820B

ICD-9 Finland

Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,NEFR SDR]

+∞

13.6

N06.0

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, minor glomerular abnormality

+∞

13.6

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

+∞

13.6

N083, E102

ICD-10 Finland

+∞

13.6

D638, N180

ICD-10 Finland

141.3

13.5

4059A

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA RENOVASCULARIS]

141.3

13.5

40199

ICD-8 Finland

Essential benign hypertension

4.8

13.4

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.8

13.4

151

XF612

NOMESCO Finland

Measurement of central venous pressure

18.4

13.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

13.4

177

938

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

26.0

13.4

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.4

13.2

109

J01FA06

ATC

roxithromycin; oral

1.6

13.2

508

3738

RJ210

NOMESCO Finland

40.5

13.2

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

13.1

299

C09CA07

ATC

telmisartan; oral

2.4

13.1

112

488

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

13.1

403

RS221

NOMESCO Finland

6.1

13.1

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

13.0

126

581

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

13.0

336

A10AE04

ATC

insulin glargine; parenteral

2.2

12.8

133

635

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

12.8

297

1905

H26.02

ICD-10 Finland

Presenil cataract

3.9

12.8

137

H25.1

ICD-10 Finland

Senile nuclear cataract

1.7

12.7

277

1744

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.4

12.7

185

C10AA03

ATC

pravastatin; oral

2.5

12.6

105

448

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

70.5

12.6

M01AB05

ATC

diclofenac; systemic, rectal

0.7

12.5

568

7091

RJ410

NOMESCO Finland

17.5

12.5

5813A

ICD-9 Finland

Nephrotic syndrome, With lesion of minimal change glomerulonephritis

+∞

12.5

TK823

NOMESCO Finland

Peritoneal permeability analysis

+∞

12.5

N00.3

ICD-10 Finland

Acute nephritic syndrome, Diffuse mesangial proliferative glomerulonephritis

+∞

12.5

B05D

ATC

PERITONEAL DIALYTICS

+∞

12.5

5850A

ICD-9 Finland

Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA SINE URAEMIA]

+∞

12.5

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.8

12.5

145

B01AC04

ATC

clopidogrel; oral

1.9

12.5

212

1232

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

131.1

12.5

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

131.1

12.5

PC6DE

NOMESCO Finland

131.1

12.5

A10BH05

ATC

linagliptin; oral

2.9

12.4

272

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

12.4

415

2938

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

12.1

471

3453

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.1

12.1

220

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.0

12.1

155

810

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

12.0

280

WZC30

NOMESCO Finland

Teaching

1.9

11.9

177

977

B01AB04

ATC

dalteparin; parenteral

2.8

11.9

293

NHQ40

NOMESCO Finland

Amputation of toe

5.2

11.9

RS222

NOMESCO Finland

7.1

11.8

TQW80

NOMESCO Finland

Local dermatologic skincare

3.7

11.8

137

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

14.8

11.8

O12.1

ICD-10 Finland

Gestational proteinuria

14.8

11.8

59000

ICD-8 Finland

Infections of kidney, Pyelonephritis chronica

10.6

11.8

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

11.7

221

1328

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.8

11.7

133

WX892

NOMESCO Finland

Monitored bed care

2.3

11.7

113

523

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

11.7

210

1239

D638, N189

ICD-10 Finland

65.5

11.6

ZX197

NOMESCO Finland

65.5

11.6

SPAT1262

SPAT

Handing over of treatment supplies

1.8

11.6

234

1438

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

11.2

11.5

C02EA01

ATC

6.2

11.5

GD2SN

NOMESCO Finland

Lung ventilation SPECT

9.3

11.5

N08.2*D57.8

ICD-10 Finland

Glomerular disorders in sickle-cell disorders

+∞

11.5

NFA10

NOMESCO Finland

Biopsy of soft tissue or joint of hip and thigh, percutaneous

+∞

11.5

7158

FHL

Graft removal

+∞

11.5

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

11.5

N08.3

ICD-10 Finland

Glomerular disorders in diabetes mellitus

+∞

11.5

N00.8

ICD-10 Finland

Acute nephritic syndrome, Other

+∞

11.5

N0830, E102

ICD-10 Finland

+∞

11.5

M31.7

ICD-10 Finland

Microscopic polyangiitis

121.0

11.4

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

121.0

11.4

7101

FHL

Needle biopsy in the operating room

121.0

11.4

R11

ICD-10 Finland

Nausea and vomiting

2.4

11.4

435

C02DE04

ATC

3.8

11.4

126

E0000UV

ATC

1.5

11.4

472

3504

SPAT1255

SPAT

Intravenous administration of medicine

2.4

11.4

409

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.7

11.3

283

C10AA02

ATC

lovastatin; oral

2.9

11.3

253

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.6

11.3

334

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

9.0

11.3

GD1UN

NOMESCO Finland

Lung circulation SPECT

9.7

11.3

J01CF02

ATC

cloxacillin; systemic

3.8

11.2

128

RJ190

NOMESCO Finland

25.2

11.1

K06.10

ICD-10 Finland

Gingival fibromatosis

25.2

11.1

E21.2

ICD-10 Finland

Other hyperparathyroidism

14.0

11.0

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

14.0

11.0

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.2

11.0

101

C09AA03

ATC

lisinopril; oral

2.6

11.0

302

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

5.2

10.9

H3603, E103

ICD-10 Finland

6.3

10.9

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

15.6

10.8

1XC02

NOMESCO Finland

8.3

10.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

10.8

174

990

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

10.8

216

1321

XQ848

NOMESCO Finland

Dermatological photography

3.7

10.7

128

C03AA03

ATC

hydrochlorothiazide; oral

2.1

10.7

127

642

RJ530

NOMESCO Finland

60.5

10.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.9

10.5

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.3

10.5

446

C10AX09

ATC

ezetimibe; oral

1.9

10.5

151

823

RJ420

NOMESCO Finland

14.3

10.5

R60.0

ICD-10 Finland

Localized oedema

2.0

10.5

138

730

NFA20

NOMESCO Finland

Exploration of hip joint or femur

110.8

10.4

TKA00

NOMESCO Finland

Needle biopsy of kidney or pelvis of kidney

110.8

10.4

TK830

NOMESCO Finland

Ultrafiltration

110.8

10.4

5824A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of rapidly progressive glomerulonephritis[CRESCENT GLOMERULONEPHRITIS ,EI NEFR SDR]

+∞

10.4

N08.2*D59.3

ICD-10 Finland

Glomerular disorders in haemolytic-uraemic syndrome

+∞

10.4

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

+∞

10.4

J01MA06

ATC

norfloxacin; oral

1.9

10.4

165

933

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

16.2

10.4

A07AA09

ATC

vancomycin; oral

6.4

10.3

RJ120

NOMESCO Finland

32.8

10.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

10.3

111

539

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

8.9

10.3

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.0

10.2

103

A10AA01

ATC

3.5

10.2

134

ZZA00

NOMESCO Finland

Split skin graft

3.2

10.1

167

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4.6

10.1

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.1

10.1

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

10.0

327

2280

A10AA02

ATC

3.1

10.0

180

59328

ICD-8 Finland

Other diseases of kidney and ureter, Morbi renis alii

40.4

10.0

HA1AA

NOMESCO Finland

X-ray mammography

2.5

9.9

331

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

7.1

9.8

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

20.2

9.8

H26.2

ICD-10 Finland

Complicated cataract

5.2

9.7

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

13.5

9.7

N08.30

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

55.4

9.7

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

9.6

370

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

7.9

9.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

9.6

108

536

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

9.6

405

ZXA10

NOMESCO Finland

Bilateral

1.7

9.5

217

1374

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.0

9.5

N05CF01

ATC

zopiclone; oral

1.5

9.5

396

2920

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

100.7

9.4

5672A

ICD-9 Finland

Peritonitis, Other suppurative peritonitis[PERITONITIS SUPPURATIVA DIFFUSA]

100.7

9.4

PBU99

NOMESCO Finland

Other repair after previous reconstruction of arteries of upper extremity

100.7

9.4

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.2

9.4

N04.4

ICD-10 Finland

Nephrotic syndrome, diffuse endocapillary proliferative glomerulonephritis

+∞

9.4

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

9.4

N03.6

ICD-10 Finland

Chronic nephritic syndrome, dense deposit disease

+∞

9.4

Q87.80

ICD-10 Finland

Alport syndrome

+∞

9.4

305

Kela drug reimbursment

MPA

+∞

9.4

N05.3

ICD-10 Finland

Unspecified nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

+∞

9.4

58299

ICD-8 Finland

+∞

9.4

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

9.4

5809A

ICD-9 Finland

Acute glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS ACUTA NUD,EI NEFR SDR]

+∞

9.4

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

6.1

9.2

H15.1

ICD-10 Finland

Episcleritis

5.8

9.2

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

13.8

9.2

N02BE01

ATC

paracetamol; systemic, rectal

1.5

9.2

1083

9786

R4180

NOMESCO Finland

Podiatric therapy

5.9

9.1

H3603, E113

ICD-10 Finland

7.1

9.0

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

10.1

9.0

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

3.3

9.0

132

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.1

9.0

160

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

8.9

272

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

24.2

8.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

8.9

272

1863

H02AB09

ATC

hydrocortisone; systemic

3.7

8.9

102

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

8.0

8.9

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

10.8

8.8

C01DA14

ATC

isosorbide mononitrate; oral

1.7

8.7

178

1091

C09CA03

ATC

valsartan; oral

2.0

8.7

116

615

SDA05

NOMESCO Finland

Very demanding and lengthy parodonthologic therapy

2.4

8.7

309

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.6

8.7

109

Y83.0

ICD-10 Finland

Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

50.3

8.7

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

50.3

8.7

S97

ICPC

Chronic ulcer skin

2.3

8.6

342

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

8.6

364

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

6.2

8.6

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

8.6

387

2885

K05.31

ICD-10 Finland

Periodontitis pronounced

1.9

8.5

132

740

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

4.3

8.5

TGC00

NOMESCO Finland

Bronchial lavation

3.2

8.5

138

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

27.7

8.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

8.5

133

748

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

8.5

469

SPAT1164

SPAT

Haemodialysis

90.6

8.4

3XA02

NOMESCO Finland

90.6

8.4

PB1BT

NOMESCO Finland

Extensive upper extremity artery PTA

90.6

8.4

RJ129

NOMESCO Finland

90.6

8.4

A02BA02

ATC

ranitidine; systemic

1.6

8.4

234

1564

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.7

8.4

B01AB05

ATC

enoxaparin; parenteral

1.5

8.4

354

2603

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

8.4

270

1870

5822B

ICD-9 Finland

Chronic glomerulonephritis, With lesion of membranoproliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA MESANGIOCAP,NEFR SDR]

+∞

8.3

TKA02

NOMESCO Finland

Needle biopsy of transplanted kidney

+∞

8.3

C02DC01

ATC

minoxidil; oral

+∞

8.3

5822A

ICD-9 Finland

Chronic glomerulonephritis, With lesion of membranoproliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA MESANGIOCAP,EI NEFR SDR]

+∞

8.3

D89.8

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

+∞

8.3

N04

ICD-10 Finland

Nephrotic syndrome

+∞

8.3

N06.8

ICD-10 Finland

Isolated proteinuria with specified morphological lesion, other

+∞

8.3

N0832, E102

ICD-10 Finland

+∞

8.3

N00.5

ICD-10 Finland

Acute nephritic syndrome, Diffuse mesangiocapillary glomerulonephritis

+∞

8.3

D89.9

ICD-10 Finland

Disorder involving the immune mechanism, unspecified

+∞

8.3

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

8.3

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

8.3

240

SCD02

NOMESCO Finland

Removal of tooth plaque or tartar

7.1

8.3

L82

ICD-10 Finland

Seborrhoeic keratosis

1.7

8.3

172

1060

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

8.2

400

C07AB03

ATC

atenolol; systemic

2.2

8.2

354

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

6.1

8.2

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

8.1

424

R06.0

ICD-10 Finland

Dyspnoea

1.5

8.1

281

1979

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.3

8.1

323

JN4AD

NOMESCO Finland

Body CT examination

2.0

8.1

101

522

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

33.5

8.1

K05.11

ICD-10 Finland

Gingivitis (chronic) hyperplastic

11.8

8.1

M04AA03

ATC

febuxostat; oral

9.0

8.0

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.0

8.0

150

RJ425

NOMESCO Finland

22.2

8.0

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

8.0

205

1338

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.3

8.0

331

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.3

7.9

118

ECA35

NOMESCO Finland

Complicated excision of lesion of gingiva

13.1

7.9

N04BC05

ATC

pramipexole; oral

2.1

7.9

443

WX890

NOMESCO Finland

Intesive care monitoring

6.1

7.9

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

4.7

7.8

TPX15

NOMESCO Finland

Removal of vascular injection port

9.5

7.8

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

7.8

122

687

ED1AA

NOMESCO Finland

Mandipular X-ray examination

7.0

7.8

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

7.8

388

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.8

7.7

143

852

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

7.7

206

PB1AT

NOMESCO Finland

Upper extremity artery PTA

45.2

7.7

KAS96

NOMESCO Finland

Other transplantation of kidney or related procedure

45.2

7.7

Y0699

ICD-8 Finland

Examination of the urinary and genital organs, Urinary organs. Does not include urine tests to determine endocrine and metabolic disorders (Y 00.99)

5.6

7.7

288

Kela drug reimbursment

Febuxostat

7.5

7.7

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.8

7.6

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

7.6

253

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

7.6

201

1324

Z94.1

ICD-10 Finland

Heart transplant status

11.9

7.6

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

25.1

7.6

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.5

7.5

H3600, E113

ICD-10 Finland

5.5

7.5

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

10.1

7.5

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

10.1

7.5

A10AE05

ATC

insulin detemir; parenteral

2.2

7.5

342

N30.0

ICD-10 Finland

Acute cystitis

1.8

7.5

137

812

I50.0

ICD-10 Finland

Congestive heart failure

2.0

7.4

461

TJA30

NOMESCO Finland

Peritoneal dialysis

80.5

7.4

G63.8*N18.8

ICD-10 Finland

Uraemic neuropathy

80.5

7.4

N11.0

ICD-10 Finland

Nonobstructive reflux-associated chronic pyelonephritis

80.5

7.4

K05.30

ICD-10 Finland

Periodontitis complex

1.7

7.4

153

941

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

7.4

239

1653

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

5.3

7.4

EB1WA

NOMESCO Finland

7.7

7.4

A41.8

ICD-10 Finland

Other specified sepsis

3.9

7.4

KFD20

NOMESCO Finland

Excision of hydrocele of testis

3.8

7.4

C07FB02

ATC

metoprolol and felodipine; systemic

3.0

7.4

145

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

7.3

400

3082

5990B

ICD-9 Finland

Other disorders of urethra and urinary tract, Urinary tract infection, site not specified[INFECTIO VIARUM URINARIUM ACUTA]

8.4

7.3

N082, D899

ICD-10 Finland

+∞

7.3

N05.2

ICD-10 Finland

Unspecified nephritic syndrome, diffuse membranous glomerulonephritis

+∞

7.3

N0830, E112

ICD-10 Finland

+∞

7.3

D89.0

ICD-10 Finland

Polyclonal hypergammaglobulinaemia

+∞

7.3

N08.2*D89.1

ICD-10 Finland

Glomerular disorders in cryoglobulinaemia

+∞

7.3

N08.5*M30.0

ICD-10 Finland

Glomerular disorders in polyarteritis nodosa

+∞

7.3

XQ834

NOMESCO Finland

Exercise challenge test

+∞

7.3

5818X

ICD-9 Finland

Nephrotic syndrome, With other specified pathological lesion in kidney

+∞

7.3

4464A

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Wegener's granulomatosis

+∞

7.3

Z50.1

ICD-10 Finland

Other physical therapy

2.2

7.2

347

CKC10

NOMESCO Finland

Local photocoagulation of retina

4.3

7.2

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.7

7.2

172

RJ126

NOMESCO Finland

30.2

7.1

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

30.2

7.1

J01CF05

ATC

flucloxacillin; systemic

2.5

7.1

216

4029B

ICD-9 Finland

Hypertensive heart disease, Unspecified[CUM DECOMPENSATIONE CORDIS (WHO III)]

20.1

7.1

XQ902

NOMESCO Finland

Other photography

8.0

7.1

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

7.1

281

2032

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.2

7.1

112

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

7.1

542

4429

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

8.8

7.0

QDH05

NOMESCO Finland

Correction of deformity of toe nail

10.1

7.0

T89

ICPC

Diabetes insulin dependent

2.5

7.0

201

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

3.5

7.0

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

7.0

410

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.9

7.0

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.9

7.0

AN1

Coronary angiography

1.7

7.0

144

885

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.8

7.0

147

WX320

NOMESCO Finland

Spinalanesthesy

1.5

6.9

254

1802

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

6.9

100

548

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

4.6

6.9

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

6.9

319

M05BA01

ATC

etidronic acid; systemic

13.8

6.9

T92

ICPC

Gout

3.3

6.9

C07AB08

ATC

celiprolol; oral

2.9

6.9

142

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

6.7

6.8

K01.0

ICD-10 Finland

Embedded teeth

4.2

6.8

A01AB09

ATC

miconazole; local oral

1.9

6.8

543

XF402

NOMESCO Finland

ECG with work load test

1.7

6.8

133

807

J01CA08

ATC

pivmecillinam; oral

1.4

6.8

359

2748

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

6.8

281

PG5ST

NOMESCO Finland

Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance

40.2

6.8

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

16.8

6.7

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.2

6.7

316

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

4.7

6.7

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

4.1

6.7

EBA10

NOMESCO Finland

Surgical removal of tooth

1.7

6.7

143

887

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

6.7

122

725

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.4

6.7

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

5.2

6.6

E000002

ATC

1.7

6.6

126

755

KA3EB

NOMESCO Finland

Antegrade pyelography

7.8

6.6

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.8

6.6

147

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

3.3

6.6

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

6.6

105

596

RJ414

NOMESCO Finland

12.3

6.6

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.7

6.5

135

831

E000006

ATC

2.0

6.5

436

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.7

6.5

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.1

6.5

331

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.1

6.5

318

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

6.4

126

762

A10BH02

ATC

vildagliptin; oral

3.2

6.4

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.2

6.4

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.9

6.4

130

B02.9

ICD-10 Finland

Zoster without complication

2.1

6.4

359

KAB00

NOMESCO Finland

Biopsy of kidney or pelvis of kidney

70.1

6.4

PH1BC

NOMESCO Finland

Extensive ultrasound examination of upper extremity veins

70.1

6.4

25004

ICD-8 Finland

Diabetes mellitus, Nephropathia diabetica. Polyneuritis diabetica

70.1

6.4

T83.8

ICD-10 Finland

Other complications of genitourinary prosthetic devices, implants and grafts

70.1

6.4

RJ124

NOMESCO Finland

70.1

6.4

E87.7

ICD-10 Finland

Fluid overload

70.1

6.4

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

14.4

6.4

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

6.4

551

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

6.4

313

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

6.3

252

1821

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.5

6.3

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.1

6.3

355

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

6.3

115

684

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

6.3

450

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

6.3

465

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.4

6.3

208

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

6.3

260

I50.1

ICD-10 Finland

Left ventricular failure

2.2

6.3

281

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

6.3

319

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

6.3

251

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

18.1

6.3

RS321

NOMESCO Finland

18.1

6.3

A12AA06

ATC

calcium lactate gluconate; oral

18.1

6.3

S18

ICPC

Laceration/cut

1.4

6.3

480

3902

PBL99

NOMESCO Finland

Construction of other arteriovenous fistula of upper extremity

+∞

6.3

N05.0

ICD-10 Finland

Unspecified nephritic syndrome, minor glomerular abnormality

+∞

6.3

5838X

ICD-9 Finland

Nephritis and nephropathy, not specified as acute or chronic, With other specified pathological lesion in kidney[NEPHRITIS INTERSTITIALIS CHRONICA ALIA DEFINITA]

+∞

6.3

N08.4*E85.9

ICD-10 Finland

Glomerular disorders in amyloidosis

+∞

6.3

N02.8

ICD-10 Finland

Recurrent and persistent haematuria, other

+∞

6.3

N00.7

ICD-10 Finland

Acute nephritic syndrome, Diffuse crescentic glomerulonephritis

+∞

6.3

N08.8

ICD-10 Finland

Glomerular disorders in other diseases classified elsewhere

+∞

6.3

N082, Z940

ICD-10 Finland

+∞

6.3

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

6.2

315

2385

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

4.3

6.2

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.4

6.2

202

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

4.8

6.2

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

26.8

6.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

6.2

209

1454

E000001

ATC

1.5

6.2

228

1619

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.6

6.2

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.1

6.2

101

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

6.2

184

GD1LA

NOMESCO Finland

3.9

6.2

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.6

6.2

159

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

5.1

6.2

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

6.2

177

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.3

6.2

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.3

6.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

6.1

111

660

KH1EE

NOMESCO Finland

Urologic ultrasound examination

8.6

6.1

Z94.4

ICD-10 Finland

Liver transplant status

8.6

6.1

D07AB08

ATC

desonide; topical

1.7

6.1

126

779

L73.8

ICD-10 Finland

Other specified follicular disorders

4.9

6.1

XQ845

NOMESCO Finland

Dermatoscopy

4.4

6.0

N43.0

ICD-10 Finland

Encysted hydrocele

4.4

6.0

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

6.0

506

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.7

6.0

147

KAC00

NOMESCO Finland

Nephrectomy

10.1

6.0

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

10.1

6.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

6.0

247

1794

NFQ20

NOMESCO Finland

Amputation of femur

5.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

304

241

15.58

323.31

8.7

5.5

iu/ml

592.0

389.1

0.33

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

695

798

15.42

307.65

11.2

3.1

ng/l

172.7

78.0

26.41

644

703

(3010375) cycloSPORINE [Mass/volume] in Blood

257

65.84

307.65

23.5

29.9

ug/l

88.1

137.9

4.19

222

(3020779) Urea [Moles/volume] in Serum or Plasma

857

1034

18.11

307.65

21.8

6.4

mmol/l

12.9

9.1

33.19

841

987

(40768446) Kidney Pathology biopsy report

253

178.98

307.65

1.9

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

250

74.87

307.65

32.4

28.2

ug/l

6.6

7.6

1.86

227

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

460

308

21.14

307.65

7.0

3.0

mg/l

2.0

1.5

11.56

443

281

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

277

181

18.56

307.65

4.1

2.8

u/ml

114.2

2470.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

927

1519

14.46

307.65

22.9

4.7

mmol/l

1.1

1.0

20.30

914

1402

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

252

187

16.01

276.97

9.7

2.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

190

27.07

270.86

2.7

2.2

g/24h

0.7

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

636

1562

6.35

263.61

8.9

2.3

24.4

23.2

1.35

596

1335

(3004789) Transferrin [Mass/volume] in Serum or Plasma

645

1673

6.03

249.96

8.8

2.2

g/l

2.0

2.3

44.13

636

1551

(3000850) Epithelial cells [#/volume] in Urine

787

2480

5.60

242.18

8.2

2.4

e6/l

3.0

5.2

5.81

749

2192

(3022948) Iron [Moles/volume] in Serum or Plasma

660

1802

5.77

239.92

8.6

2.3

umol/l

12.2

13.3

4.44

652

1664

(3020682) Albumin/Creatinine [Ratio] in Urine

969

3706

5.60

233.70

12.9

3.8

mg/mmol

47.8

6.8

35.09

883

2366

(3042733) HLA Ab [Presence] in Serum

138

44.62

230.87

7.4

4.0

—

(3012516) Albumin [Mass/volume] in Urine

935

3505

5.46

230.17

10.1

3.1

mg/l

390.1

288.1

0.50

848

2263

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

357

557

8.11

229.16

11.9

3.6

mmol/l

23.1

24.3

9.60

323

508

(3009508) Creatinine [Moles/volume] in Urine

956

3749

5.31

219.61

10.3

3.0

mmol/l

6.4

8.0

32.71

915

3138

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

228

221

12.00

211.26

2.9

1.3

u/ml

122.2

124.8

0.05

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

231

238

11.30

205.12

2.9

1.3

—

(3002032) Base excess in Venous blood by calculation

469

1092

5.80

199.97

12.8

3.3

mmol/l

0.3

2.1

18.97

403

869

(3002582) Erythrocytes [#/volume] in Urine

904

3594

4.84

198.37

10.6

3.1

e6/l

42.2

87.9

1.61

831

2786

(3021447) Carbon dioxide [Partial pressure] in Venous blood

467

1097

5.74

196.88

12.7

3.3

kpa

5.8

5.9

0.22

462

1069

(3024561) Albumin [Mass/volume] in Serum or Plasma

1084

5025

5.22

192.59

16.7

4.8

g/l

34.3

35.5

10.30

1060

4693

(3030467) Casts [#/volume] in Urine by Automated count

841

3266

4.61

187.72

9.9

3.0

e6/l

0.2

0.5

10.28

746

2476

(3026782) Osmolality of Urine

686

2320

4.62

183.37

9.0

2.6

mosm/kgh2o

489.1

565.8

23.44

648

1992

(3026493) Urate [Moles/volume] in Serum or Plasma

822

3196

4.50

181.76

6.4

2.6

umol/l

795.7

6101.0

7.32

783

2771

(36304419) Bacteria [Presence] in Urine

820

3183

4.50

181.71

9.3

2.9

—

(3000991) Gas panel - Venous blood

430

1013

5.56

179.21

15.8

8.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

159

113

15.63

177.33

1.1

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

301

512

7.11

176.13

2.3

1.9

g/l

1.6

1.5

0.18

272

446

(3018418) pH of Serum or Plasma

834

3357

4.36

173.90

20.8

3.6

7.4

10.62

222

652

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

159

120

14.71

171.36

2.2

2.5

—

(3018095) Leukocytes [#/volume] in Urine

940

4158

4.40

170.92

12.2

3.5

e6/l

30.8

104.1

2.67

845

2983

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

209

247

9.68

166.92

1.8

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

204

238

9.77

164.48

1.9

1.2

u/ml

266.6

268.7

0.03

160

143

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

389

932

5.29

157.36

4.7

2.6

ml/min/173m2

41.4

67.9

26.42

235

364

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

229

332

7.97

154.30

3.0

1.4

g/l

1.1

1.2

3.34

221

314

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

35.31

151.46

1.1

1.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

223

322

7.97

150.68

3.0

1.4

g/l

0.2

0.14

213

307

(3024354) Oxygen [Partial pressure] in Venous blood

377

915

5.17

149.64

8.5

2.8

kpa

6.0

4.5

12.83

372

892

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

31.99

147.02

1.1

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

959

4642

3.98

145.23

4.1

2.2

nmol/l

73.2

76.6

3.78

932

4149

(3017143) Hepatitis C virus Ab [Presence] in Serum

447

1278

4.57

144.33

3.8

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

123

16.67

143.38

1.4

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

235

388

7.00

140.18

3.6

2.7

u/ml

0.3

0.4

1.33

113

214

(3012095) Magnesium [Moles/volume] in Serum or Plasma

559

1941

4.01

137.51

5.1

3.5

mmol/l

0.8

2.47

550

1819

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1079

5793

4.11

136.87

32.0

6.4

mmol/l

1.2

1.87

951

4891

(3012565) Volume of 24 hour Urine

102

21.39

134.49

2.9

2.8

1799.4

2080.8

0.91

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

133

243.08

131.18

4.2

6.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

261

510

5.99

131.13

2.0

1.3

u/ml

18.5

18.1

0.01

(3048929) Epstein Barr virus Ab [Presence] in Serum

220

363

6.94

131.02

1.8

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

215

350

7.01

129.66

2.8

4.0

mg/l

91.8

66.5

0.40

149

286

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

215

351

6.99

129.30

2.8

4.0

mg/l

51.7

41.3

0.55

148

290

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

212

343

7.04

128.56

2.8

4.0

ratio

2.5

1.7

0.24

(21494890) Protein electrophoresis panel - 24 hour Urine

127

106

13.00

128.36

1.8

2.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1004

5275

3.76

128.31

26.2

5.8

mmol/l

1.2

11.14

986

4792

(1616796) Gas panel - Central venous blood

188

269

7.85

127.46

8.3

3.2

—

(3024471) HLA-A [Type]

24.84

124.95

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

180

254

7.92

123.43

2.4

4.4

—

(3024932) HLA-DR beta [Type]

24.55

123.00

1.0

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

467

1556

3.91

119.76

3.8

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

350

947

4.52

119.44

3.2

2.8

g/l

64.0

66.5

6.43

337

866

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

537

1982

3.67

117.96

6.0

2.7

e6/l

0.5

1.1

5.82

364

1132

(3018677) aPTT in Platelet poor plasma by Coagulation assay

513

1866

3.66

114.79

3.4

2.1

29.2

29.9

2.39

506

1803

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

305

775

4.69

112.30

7.4

3.3

mmol/l

0.6

1.8

6.24

197

578

(3009343) pH of Capillary blood

309

810

4.55

109.18

7.6

3.3

7.4

0.95

(3004588) Protein electrophoresis panel - Serum or Plasma

302

778

4.61

109.10

2.5

2.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

310

817

4.53

108.75

7.6

3.3

kpa

4.9

5.2

8.30

298

760

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

414

1350

3.86

108.37

3.6

4.2

u/l

237.2

248.1

0.75

404

1276

(3016750) Collection duration of Urine

101

13.64

105.92

3.6

2.2

min

500.3

497.5

0.08

(42870588) Differential panel, method unspecified - Blood

809

4035

3.19

105.70

9.6

5.9

—

(3024928) Oxygen saturation in Venous blood

168

261

7.13

105.28

6.8

3.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

108

100

11.56

101.84

1.2

1.1

u/ml

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

20.52

101.43

3.1

2.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

494

1880

3.43

101.19

6.8

2.8

e6/l

1.6

1.7

0.22

322

1035

(3037121) Protein [Mass/volume] in Urine

210

428

5.55

99.77

7.9

3.1

g/l

1.0

0.2

5.02

166

174

(3015235) Bicarbonate [Moles/volume] in Capillary blood

182

325

6.24

99.48

4.7

2.7

mmol/l

22.7

24.8

7.92

174

282

(46235355) HIV 1 and 2 tests - Meaningful Use set

493

1910

3.36

97.61

3.8

1.7

—

(3004775) Volume in Urine collected for unspecified duration

104

11.22

96.21

3.4

2.3

802.8

615.1

3.07

(3023520) Reticulocytes [#/volume] in Blood

328

983

3.99

95.94

4.5

2.7

e9/l

68.1

70.8

0.65

230

763

(3027945) Reticulocytes/100 erythrocytes in Blood

388

1337

3.57

91.98

4.8

2.6

1.9

1.8

0.89

377

1187

(3035350) Ketones [Presence] in Urine by Test strip

978

5720

3.06

91.41

9.6

3.4

estimate

0.0

0.00

299

1077

(3021601) Nitrite [Presence] in Urine by Test strip

977

5712

3.06

91.36

12.4

4.6

estimate

0.0

0.50

307

1094

(3014148) Varicella zoster virus Ab [Titer] in Serum

110

122

9.65

91.20

1.1

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

983

5786

3.05

90.41

9.6

3.4

estimate

0.0

0.80

297

1039

(3011648) Oxygen content in Venous blood

10.97

88.57

5.7

3.2

10.7

11.0

0.27

(3021901) Oxygen saturation in Capillary blood

142

233

6.63

84.11

4.4

2.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

359

1266

3.42

81.10

5.3

3.2

—

(3001604) Monocytes [#/volume] in Blood

978

5969

2.85

79.83

10.9

5.8

e9/l

0.6

6.40

885

5152

(3006315) Basophils [#/volume] in Blood

978

5989

2.84

78.95

10.9

5.8

e9/l

0.0

0.11

885

5173

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

185

412

4.98

78.83

2.4

1.5

titre

200.8

165.7

0.23

(3022096) Basophils/100 leukocytes in Blood

916

5466

2.75

77.08

11.6

6.0

0.6

0.7

2.96

895

5093

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

105

137

8.17

76.37

1.1

—

(3042936) Bacteria identified in Isolate by Culture

428

1735

3.06

75.93

3.0

2.1

—

(3013115) Eosinophils [#/volume] in Blood

990

6190

2.78

75.11

11.4

6.1

e9/l

0.2

0.78

904

5452

(3006504) Eosinophils/100 leukocytes in Blood

929

5632

2.72

74.89

11.6

6.0

2.8

2.9

0.04

910

5239

(3019198) Lymphocytes [#/volume] in Blood

983

6134

2.76

74.70

11.1

5.8

e9/l

1.9

0.23

900

5403

(3019069) Monocytes/100 leukocytes in Blood

931

5660

2.71

74.46

11.8

6.3

8.9

8.7

1.12

910

5290

(40767503) Oxygen content in Capillary blood by calculation

140

257

5.91

73.89

4.5

2.4

16.1

16.5

0.48

118

133

(3023368) Bacteria identified in Blood by Culture

652

3339

2.69

73.84

8.7

4.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

938

5797

2.66

71.30

11.6

6.1

24.9

27.6

12.00

917

5396

(3012501) Base excess in Blood by calculation

140

267

5.68

70.90

9.5

3.9

mmol/l

2.2

2.4

0.54

182

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

151

310

5.31

70.50

2.8

1.2

iu/ml

12.4

5.4

—

(3021589) Normoblasts [#/volume] in Blood

882

5321

2.61

70.00

23.4

9.3

e9/l

0.0

0.68

733

4379

(3018010) Neutrophils/100 leukocytes in Blood

922

5714

2.60

68.63

11.0

5.9

60.1

57.4

9.97

898

5341

(3001122) Ferritin [Mass/volume] in Serum or Plasma

831

4937

2.54

67.14

8.1

2.7

ug/l

221.4

142.3

14.40

811

4551

(3011397) Hemoglobin [Presence] in Urine by Test strip

538

2606

2.66

66.81

7.5

3.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

263

857

3.51

66.34

2.2

1.6

—

(3010421) pH of Blood

147

320

4.99

64.02

10.8

3.7

7.4

7.63

140

263

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

116

205

6.05

63.53

3.0

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1154

8135

2.84

63.52

12.6

4.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

131

264

5.34

62.31

3.8

2.1

g/l

125.0

132.3

2.07

123

189

(3014111) Lactate [Moles/volume] in Serum or Plasma

297

1098

3.13

60.58

12.1

7.6

mmol/l

1.2

1.4

3.04

289

1056

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

140

307

4.93

60.38

4.9

2.4

ug/min

413.4

89.6

3.66

121

191

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

76.81

58.56

14.1

11.6

mmol/l

5.0

6.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

122

247

5.29

57.66

4.7

3.7

60.1

57.2

1.52

122

247

(3013650) Neutrophils [#/volume] in Blood by Automated count

1012

6913

2.44

55.57

13.9

9.1

e9/l

4.5

4.1

4.87

925

6051

(3030905) Polymorphonuclear cells [#/volume] in Blood

117

237

5.27

55.23

4.2

3.4

e9/l

4.4

4.2

0.50

117

237

(3005719) IgG [Mass/volume] in Serum or Plasma

256

915

3.17

54.97

3.9

2.7

g/l

9.3

10.7

4.16

242

838

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

422

1973

2.59

54.63

2.5

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

671

3884

2.32

53.77

7.0

3.3

mmol/l

2.3

2.4

3.03

635

3393

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

330

1374

2.80

53.73

2.1

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

565

3040

2.38

53.64

7.2

4.0

98.0

88.7

11.47

549

2964

(3002179) Metamyelocytes/100 leukocytes in Blood

252

909

3.13

53.17

6.2

4.1

0.6

0.10

224

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

328

1377

2.77

52.45

2.2

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

408

4.09

52.05

2.5

2.8

g/l

9.5

10.5

1.69

140

352

(3017181) Myelocytes/100 leukocytes in Blood

267

1009

3.00

51.85

6.6

4.2

1.0

0.9

0.23

114

304

(3025159) Blasts/100 leukocytes in Blood

247

894

3.11

51.73

6.7

4.4

0.0

0.5

0.74

102

238

(3021879) Hepatitis B virus core Ab [Presence] in Serum

235

827

3.19

51.62

2.3

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

436

3.96

51.23

2.5

2.7

g/l

7.6

7.3

0.92

130

341

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

436

3.96

51.23

2.5

2.7

g/l

4.0

3.8

0.96

129

327

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

436

3.96

51.23

2.5

2.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

140

353

4.27

50.53

2.6

1.3

—

(3037756) Immunofixation for Serum or Plasma

114

244

4.98

50.45

1.5

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

255

954

3.02

50.32

6.8

4.3

0.0

0.1

1.23

109

278

(3031040) Bacteria [#/volume] in Urine by Automated count

1067

7677

2.37

48.67

8.3

4.1

e6/l

112.5

1440.1

1.26

117

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

133

332

4.30

48.61

1.6

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

350

1579

2.59

48.07

12.5

7.3

mmol/l

103.3

104.4

2.91

344

1549

(3007853) Bacteria identified in Skin by Aerobe culture

319

1383

2.66

47.46

2.6

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

135

347

4.18

47.45

4.0

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

555

3094

2.26

47.21

11.3

3.7

estimate

0.0

0.80

241

1049

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

123

296

4.44

47.11

1.7

—

(3026008) Bacteria identified in Urine by Culture

572

3241

2.24

46.64

3.9

3.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

124

306

4.33

45.96

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

147

414

3.83

45.48

2.5

2.7

g/l

3.2

3.1

1.14

129

333

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

103

221

4.93

45.39

1.7

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

125

314

4.25

45.26

2.5

2.8

g/l

0.0

0.00

118

291

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

130

337

4.13

45.13

2.6

2.7

g/l

0.2

0.0

0.47

123

312

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

125

317

4.21

44.68

2.6

2.8

g/l

0.0

0.50

118

292

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

137

375

3.92

44.11

2.6

2.8

g/l

0.4

1.4

2.78

125

334

(3022313) Gas panel - Capillary blood

181

596

3.32

44.09

9.0

3.4

—

(3037522) Nuclear Ab [Titer] in Serum

337

1552

2.51

43.92

1.5

1.3

titre

358.9

487.3

1.35

322

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

130

354

3.93

42.13

2.6

g/l

36.3

37.7

1.40

121

309

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

140

5.82

41.88

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

177

5.22

41.76

1.8

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1189

9219

2.42

41.71

17.3

7.5

u/l

79.3

78.4

0.31

1163

8690

(3032080) INR in Blood by Coagulation assay

754

4914

2.08

41.41

18.0

9.2

inr

1.2

1.3

0.48

288

1430

(40761535) Cells panel - Urine sediment

239

960

2.77

40.88

9.5

3.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

127

348

3.90

40.77

2.9

1.7

—

(40758558) Short blood count panel - Blood

523

3016

2.13

39.37

8.6

6.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

219

4.62

39.24

1.9

1.2

—

(3036603) Volume of Urine

7.58

38.33

2.0

1.4

1817.3

1796.4

0.02

(3028271) Lactate [Moles/volume] in Capillary blood

185

4.87

37.73

2.7

1.8

mmol/l

1.4

1.7

2.04

179

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

109

6.19

37.38

1.3

1.2

u/l

93.2

53.2

1.53

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

508

2944

2.10

37.36

3.0

2.2

mg/l

3.2

3.0

0.76

462

2489

(3047189) Immunofixation for 24 hour Urine

9.10

37.32

1.7

1.9

—

(40761536) Microorganisms panel - Urine sediment

240

1010

2.64

37.25

15.0

3.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

527

3150

2.04

35.22

9.8

3.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

679

4439

1.97

35.11

10.7

3.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

66.64

34.14

2.8

4.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

107

295

3.83

33.98

1.5

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

100

6.10

33.56

1.9

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

185

724

2.78

32.93

2.4

1.8

g/l

1.3

1.4

0.22

173

672

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

119

360

3.51

32.93

3.6

2.6

g/l

4.0

3.7

0.91

114

342

(4035726)

231

1016

2.51

32.47

1.6

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

8.58

31.84

1.7

5.6

mg/l

59.5

66.0

0.23

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

180

712

2.74

31.34

1.9

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

202

861

2.56

30.23

2.8

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

460

2740

1.98

30.15

1.9

1.6

nmol/l

20.1

20.3

0.11

429

2336

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

575

3721

1.89

29.19

4.2

2.5

u/l

67.2

57.6

1.86

552

3461

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

170

4.46

29.04

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

937

7102

1.86

28.23

12.4

4.9

mmol/l

6.9

6.7

1.85

912

6666

(40761539) Cells [Type] in Urine sediment by Light microscopy

12.39

28.16

1.6

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

166

4.44

28.11

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

443

2658

1.95

28.09

9.2

4.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

7.93

27.73

1.2

1.0

miu/ml

1825.7

1702.2

0.23

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

21.29

27.69

2.6

1.8

ng/l

169.6

145.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

212

3.98

27.63

1.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

470

2892

1.91

27.53

3.6

2.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

139

514

2.88

27.38

10.5

3.7

mmol/l

23.6

25.0

6.96

130

487

(3044640) Blood type and Crossmatch panel - Blood

573

3766

1.85

27.23

4.0

2.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

840

6221

1.80

26.62

7.4

6.4

umol/l

9.5

11.8

13.54

808

5919

(3052851) Hemolysis interference index of Serum or Plasma

103

328

3.30

26.23

4.2

3.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

137

515

2.83

26.16

2.4

1.9

ug/l

5.2

2.1

0.63

129

464

(3019309) Folate [Moles/volume] in Red Blood Cells

368

2121

1.98

25.95

2.1

1.7

nmol/l

1332.3

1157.1

2.19

306

1618

(3036481) Cortisol [Moles/volume] in Serum or Plasma

222

1060

2.29

25.62

2.2

nmol/l

328.0

368.8

2.62

212

976

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

111

380

3.08

25.05

2.1

1.6

iu/ml

2.2

0.1

0.69

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

542

3587

1.80

24.58

2.6

2.2

u/l

185.3

243.0

0.77

521

3383

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

183

3.96

23.92

1.7

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

161

4.18

23.89

1.7

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

12.18

23.88

1.7

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

12.18

23.88

1.7

1.1

101.9

97.1

0.33

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

102

5.04

23.32

1.7

1.8

—

(3025315) Body weight

45.75

22.40

4.7

3.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

107

390

2.88

21.59

2.8

2.4

93.4

89.9

0.67

100

370

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

129

529

2.57

20.70

1.6

1.9

u/l

39.8

39.0

0.14

117

465

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

11.20

19.80

1.3

1.9

—

(3049717) Cytology report of Urine Cyto stain

125

519

2.54

19.54

2.4

2.6

—

(3025941) Bacteria identified in Stool by Culture

141

625

2.39

19.13

1.4

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

211

1103

2.06

19.08

3.4

2.5

u/l

99.4

40.2

0.47

186

955

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.11

18.62

1.8

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

16.16

18.52

1.4

1.5

—

(3016502) Oxygen saturation in Arterial blood

231

1274

1.96

17.92

11.2

8.5

94.2

95.6

2.58

226

1232

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

263

3.03

17.44

1.6

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

249

1427

1.89

17.18

10.7

8.1

kpa

5.0

5.1

0.98

243

1366

(3027801) Oxygen [Partial pressure] in Arterial blood

249

1428

1.89

17.14

10.7

8.1

kpa

11.0

12.1

2.72

242

1370

(3036489) Thrombin time

109

459

2.48

16.52

2.7

2.2

24.0

21.6

1.61

411

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.17

16.51

1.9

1.6

—

(3045414) Leukocytes [Presence] in Urine

117

512

2.39

16.31

3.4

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.09

16.24

1.9

1.6

—

(3003396) Base excess in Arterial blood by calculation

243

1423

1.85

15.57

10.9

8.1

mmol/l

-0.2

1.2

4.72

190

1107

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

9.15

15.56

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

139

670

2.18

15.43

13.4

10.5

mmol/l

23.3

24.5

3.65

131

633

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

7.43

15.27

1.3

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

208

1169

1.91

15.12

11.8

9.1

g/l

110.7

123.2

13.23

203

1129

(3007164) IgA [Mass/volume] in Serum or Plasma

341

2240

1.68

14.54

1.9

1.5

g/l

2.9

2.5

2.51

253

1391

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

629

4785

1.54

14.45

2.2

2.0

pmol/l

101.2

94.3

2.89

349

2598

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

12.84

14.27

3.3

5.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1035

8792

1.58

14.26

7.1

3.9

mm/h

22.5

11.7

44.35

996

8109

(4062490)

111

3.86

14.19

1.9

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

111

3.86

14.19

2.0

1.3

g/l

7.8

7.0

0.29

(3024139) IgG subclass 3 [Mass/volume] in Serum

111

3.86

14.19

2.0

1.3

g/l

0.5

0.4

1.20

(3028192) IgG subclass 2 [Mass/volume] in Serum

111

3.86

14.19

2.0

1.3

g/l

2.8

0.01

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

153

792

2.04

14.08

13.4

10.0

0.6

0.7

1.24

153

787

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

713

5596

1.52

14.05

6.1

4.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

4.72

14.03

1.6

u/l

6.3

7.1

0.11

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

431

2.39

13.96

3.0

2.7

—

(3045424) Erythrocytes [Presence] in Urine

219

2.96

13.87

2.1

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

101

446

2.36

13.80

2.9

2.4

ug/l

566.7

540.7

0.03

101

419

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

105

3.89

13.65

1.2

1.1

titre

350.0

200.0

—

(44790047)

144

3.41

13.49

1.5

1.6

—

(44790048)

144

3.41

13.49

1.5

1.6

—

(44790049)

144

3.41

13.49

1.5

1.6

—

(44806118)

144

3.41

13.49

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

185

3.11

13.47

1.9

1.5

g/l

0.6

0.8

0.62

143

(3051651) Icteric interference index of Serum or Plasma

4.52

13.34

5.7

4.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

340

2.49

12.87

1.7

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.75

12.85

2.1

2.3

—

(3011412) CD3 cells [#/volume] in Blood

3.93

12.84

1.9

2.6

e9/l

1.0

1.2

0.53

(3017704) Immunofixation for Urine

4.55

12.63

1.3

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1237

11080

1.68

12.60

9.5

5.7

mmol/mol

40.0

39.9

0.21

1197

10280

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

152

3.23

12.40

2.4

32.9

32.8

0.05

152

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

594

4577

1.49

12.26

5.1

3.6

ng/l

79.3

59.4

0.40

484

3189

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

468

3431

1.53

12.26

3.5

3.1

ng/l

7337.0

1294.9

11.02

425

2926

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

10.09

12.24

3.4

5.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

139

737

1.98

11.94

2.0

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

206

2.84

11.74

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

6.13

11.67

12.2

7.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

326

2.44

11.57

1.6

2.1

mg/l

15.5

11.0

2.92

295

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

6.40

11.56

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

154

3.12

11.49

1.9

1.4

g/l

25.4

32.5

2.11

138

(3044927) Protein electrophoresis panel - Urine

134

3.27

11.41

1.2

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

244

2.65

11.38

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

244

2.65

11.38

1.5

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

4.27

11.30

1.8

2.4

12.6

14.2

—

(40768443) Skin Pathology biopsy report

101

486

2.16

11.26

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

6.20

11.21

12.4

7.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.49

11.10

2.0

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

190

2.86

11.09

1.1

1.2

u/ml

1.8

3.3

0.61

(3000494) Fungus identified in Specimen by Culture

230

1456

1.69

11.03

1.7

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

107

3.52

11.03

5.3

4.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.42

11.00

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.42

11.00

1.5

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

191

1151

1.76

10.94

1.8

2.3

g/l

0.2

2.65

178

1075

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

249

2.60

10.94

2.0

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

1126

9983

1.52

10.70

48.0

17.0

14.1

13.7

16.37

1118

9766

(3023199) Leukocytes [#/volume] in Pleural fluid

135

3.17

10.62

1.7

1.4

e6/l

651.6

1663.2

3.17

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

217

1368

1.69

10.55

3.6

2.8

umol/l

6.4

8.3

1.05

194

1196

(3025549) Creatine [Moles/time] in 24 hour Urine

18.92

10.26

1.1

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

113

3.33

10.16

4.7

2.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.32

10.12

1.8

1.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1250

11393

1.60

9.97

38.7

12.9

ml/min/173m2

56.7

81.9

128.90

1153

9408

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

190

2.74

9.96

1.2

u/ml

3.5

6.2

0.72

(3042631) Mycobacterium sp identified in Specimen

169

2.84

9.81

2.8

2.9

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

307

2.34

9.77

1.6

1.2

u/ml

24.1

25.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

123

671

1.91

9.72

14.6

11.2

—

(40768806) Pleura Pathology biopsy report

128

3.10

9.55

1.9

1.5

—

(4268621)

123

3.14

9.52

2.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

7.71

9.28

1.5

7.0

4.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

509

3964

1.43

9.28

3.8

3.3

u/l

31.6

38.1

0.84

493

3769

(3000093) Morphology [Interpretation] in Blood Narrative

110

3.23

9.21

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1298

11990

1.63

9.20

43.8

14.1

mg/l

19.5

25.0

12.26

1175

9481

(3021788) Differential panel - Synovial fluid

222

2.53

9.19

2.0

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

423

3190

1.45

9.14

2.1

1.6

mmol/l

1.7

1.4

2.54

383

2662

(3020891) Body temperature

491

2.02

9.14

9.7

4.6

—

(3012441) Differential panel - Pleural fluid

121

3.11

9.13

1.9

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

137

2.97

9.12

1.4

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

285

2.34

9.09

1.6

1.2

u/ml

15.7

2.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

128

3.02

8.92

1.4

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

289

2.31

8.81

1.6

1.2

u/ml

7.1

9.3

—

(3000034) Microalbumin [Mass/volume] in Urine

120

3.05

8.61

7.4

3.1

mg/l

434.0

22.3

2.29

(3028308) Erythrocytes [#/volume] in Pleural fluid

121

3.02

8.50

1.7

1.4

e6/l

225227.6

79509.8

0.29

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

149

2.80

8.43

3.0

1.9

—

1346.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

5.20

8.41

1.1

1.0

—

(3004451) EKG impression Narrative

3.78

8.36

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

117

3.04

8.34

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

117

3.04

8.34

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

117

3.04

8.34

1.4

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.86

8.26

1.2

ratio

1.0

1.1

0.55

(3042111) Morphology [Interpretation] in Bone marrow Narrative

198

2.52

8.20

1.8

1.7

—

(3019060) Gas panel - Arterial blood

135

802

1.75

8.10

5.7

5.2

—

(3045788) Cell count panel - Pleural fluid

106

3.06

7.76

1.7

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

346

2.10

7.73

1.6

1.5

ug/g

237.5

284.5

1.21

204

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.00

7.62

3.2

4.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

250

2.29

7.56

1.6

1.4

—

(3044889) 12 lead EKG panel

961

8497

1.37

7.49

4.9

3.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.21

7.45

1.1

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

131

2.79

7.41

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

333

2490

1.43

7.32

1.9

1.7

pmol/l

458.1

28585599.6

2.12

306

2078

(3003181) Sodium [Moles/volume] in Urine

191

2.45

7.30

1.6

1.3

mmol/l

55.4

63.4

0.85

157

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

105

2.99

7.25

1.1

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1241

11494

1.47

7.14

6.5

3.9

mmol/l

1.6

1.3

10.38

1203

10543

(3019550) Sodium [Moles/volume] in Serum or Plasma

1322

12418

1.56

6.98

50.4

16.1

mmol/l

139.3

139.7

5.94

1307

12102

(3022217) INR in Platelet poor plasma by Coagulation assay

219

1530

1.51

6.78

32.0

24.4

inr

1.4

1.3

0.42

212

(3000475) Leukocytes [#/volume] in Synovial fluid

309

2.08

6.78

2.0

1.7

e6/l

21377.0

16575.1

0.18

224

(3036782) Glucose [Moles/volume] in Pleural fluid

115

2.82

6.76

1.8

1.3

mmol/l

6.9

6.5

0.23

108

(3034426) Prothrombin time (PT)

4.29

6.76

1.1

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

342

2612

1.40

6.60

2.3

1.8

mg/l

1.7

1.2

2.88

289

2005

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

12.30

6.58

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.20

6.58

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.20

6.58

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.20

6.58

1.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1323

12459

1.54

6.57

53.1

16.2

mmol/l

4.2

4.0

61.84

1306

12129

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

117

2.77

6.56

1.9

1.4

26.1

30.8

0.31

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

317

2.03

6.35

1.2

1.3

miu/ml

172.5

213.7

0.28

140

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.25

6.29

1.6

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.70

6.22

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.08

6.21

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.08

6.21

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.08

6.21

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

161

1073

1.56

6.19

2.6

2.4

ug/l

5.2

7.8

1.38

144

957

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

2.94

6.17

2.0

u/field

0.7

1.9

1.04

(3003694) ABO and Rh group [Type] in Blood

412

3280

1.35

6.09

1.6

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.22

5.88

2.2

1.4

—

(3035880) pH of Pleural fluid

3.31

5.87

1.6

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.49

5.74

1.2

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.49

5.74

1.2

1.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

3.73

5.65

1.9

1.3

66.9

58.8

0.33

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

152

2.40

5.58

2.1

1.5

64.9

58.0

0.48

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

303

2333

1.37

5.48

5.3

3.7

ng/l

502.7

473.5

0.05

260

1826

(3011985) Renin [Units/volume] in Plasma

135

2.48

5.47

1.2

1.3

mu/l

84.2

45.0

0.66

120

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.36

5.45

2.4

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.36

5.45

2.4

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

119

762

1.61

5.43

8.7

7.6

mmol/l

23.1

24.6

3.66

113

712

(3023183) Ammonium ion [Moles/volume] in Plasma

288

1.98

5.36

3.9

3.2

umol/l

29.4

38.2

1.28

242

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.12

5.35

1.3

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.12

5.35

1.3

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.12

5.35

1.3

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.12

5.35

1.3

1.8

—

(40768804) Tissue Pathology biopsy report

553

4660

1.30

5.34

2.6

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1114

0.55

5.33

2.0

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.07

5.23

2.2

1.4

—

(3000330) Specific gravity of Urine by Test strip

553

1.69

5.10

10.2

3.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

3.78

5.09

2.0

1.3

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

315

1.91

5.08

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

280

2156

1.37

5.03

3.0

3.1

mmol/l

2.5

2.4

1.24

244

1905

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.30

5.03

1.1

1.2

—

(3013512) EKG study

428

3512

1.31

4.98

5.0

3.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1260

11883

1.39

4.95

7.1

4.3

mmol/l

1.4

7.40

1220

10953

(3009871) Measles virus Ab [Titer] in Serum

3.69

4.93

1.5

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

189

1365

1.44

4.93

2.4

ug/g

155.7

131.2

0.49

162

1095

(3017569) Oxygen content in Arterial blood

3.14

4.92

2.1

3.1

—

(3023419) Bacteria identified in Sputum by Culture

168

2.23

4.90

2.4

2.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.24

4.90

1.2

1.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.01

4.83

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.01

4.83

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.31

4.83

1.1

—

(3044941) Cell count panel - Synovial fluid

209

2.09

4.82

1.8

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

367

1.81

4.73

1.9

1.7

—

(3019225) pH of Specimen

163

1158

1.46

4.64

20.6

3.9

—

(3019150) Specific gravity of Urine by Refractometry

318

2528

1.33

4.60

10.5

3.7

kg/l

1.0

0.99

353

(3002256) Pathology report gross observation

205

1522

1.40

4.58

1.5

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1264

11960

1.37

4.58

7.2

4.4

mmol/l

4.4

4.6

13.69

1229

11104

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

14.06

4.58

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.79

4.53

1.3

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

242

1.97

4.53

5.3

2.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.67

4.50

2.0

2.5

e6/l

736.0

691.8

0.08

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.84

4.39

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

346

1.80

4.39

1.3

1.1

—

(3022689) Creatine [Moles/volume] in Urine

3.74

4.37

2.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

347

1.79

4.35

1.3

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

746

0.51

4.30

1.7

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.80

4.29

1.4

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

11.71

4.28

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

350

1.77

4.24

1.3

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

133

2.28

4.24

1.1

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

140

2.24

4.20

1.1

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

962

8825

1.25

4.14

4.1

3.8

pmol/l

14.8

0.09

907

8008

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.82

4.13

2.0

1.7

—

(21494755) Public health laboratory ask at order entry panel

1156

0.61

4.10

1.3

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.37

4.09

1.8

1.5

—

(3022145) Colonoscopy Study observation

177

1307

1.40

4.08

1.4

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

3.54

4.05

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

123

2.30

4.05

1.2

1.3

pmol/l

348.7

314.1

0.14

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.95

4.01

1.8

1.3

4.4

5.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

10.04

4.01

24.4

4.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

6.46

3.98

3.6

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1277

12160

1.35

3.96

7.3

4.8

mmol/l

2.5

2.8

24.70

1240

11210

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.15

3.93

1.0

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

336

1.76

3.92

1.3

1.2

titre

70.0

86.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

207

1.96

3.84

1.2

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

265

1.84

3.81

5.9

2.9

mmol/l

1.2

1.5

3.15

260

(3032057) Clostridioides difficile [Presence] in Stool

4.02

3.70

2.6

1.8

—

(3045142) Bone marrow Pathology biopsy report

129

2.19

3.65

1.6

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

103

703

1.50

3.62

1.5

1.3

u/ml

259.6

258.7

0.00

651

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

100

2.32

3.44

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

126

2.16

3.43

1.4

1.3

e6/l

228325.0

95304.3

0.25

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

640

1.50

3.36

2.3

3.5

pmol/l

4.1

4.6

4.96

564

(3027456) Digoxin [Moles/volume] in Serum or Plasma

233

1.83

3.32

3.4

3.0

nmol/l

0.8

0.20

177

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

128

2.13

3.31

1.2

1.3

nmol/l

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.49

3.30

2.6

3.0

41.7

41.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

231

1845

1.30

3.19

1.3

u/ml

19.1

12.2

0.43

717

(3034770) Mitochondria Ab [Titer] in Serum

342

1.66

3.19

1.3

1.2

titre

—

1276.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

7.52

3.05

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

299

2480

1.26

3.05

1.3

1.2

u/ml

1.0

1.8

1.53

665

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.28

3.04

1.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

140

2.02

3.01

5.9

4.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

816

7487

1.20

3.01

3.3

2.9

—

(3028433) Virus identified in Specimen by Culture

3.16

2.93

1.0

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

465

0.51

2.84

1.3

1.7

mg/l

13.0

3.6

1.08

338

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

201

1.81

2.83

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

189

0.31

2.81

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

190

0.31

2.81

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

190

0.31

2.81

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

190

0.31

2.81

1.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.52

2.70

1.6

1.2

ug/l

10.0

6.3

0.92

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

265

1.68

2.68

4.4

1.5

nmol/l

1.2

0.8

1.82

224

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

354

4088

0.82

2.59

3.6

4.1

26.8

21.3

6.67

189

1943

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.91

2.58

2.0

2.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.31

2.58

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

204

1657

1.27

2.48

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.39

2.46

1.9

2.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.82

2.46

1.3

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

432

1.50

2.46

1.2

1.1

—

0.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.30

2.41

1.1

1.2

—

(3019174) dRVVT (LA screen)

5.02

2.40

1.2

—

(40761511) CBC panel - Blood by Automated count

1298

12551

1.26

2.39

39.3

13.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

6.27

2.37

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.13

2.36

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1325

12851

1.28

2.33

47.7

16.3

umol/l

163.6

78.4

79.09

1325

12846

(3004716) Salmonella sp identified in Stool by Organism specific culture

573

1.42

2.29

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.47

2.28

1.0

1.2

—

(21494434) Karyotype in Bone marrow

113

1.96

2.26

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1323

12839

1.27

2.24

23.1

10.3

u/l

24.0

27.6

11.43

1298

12407

(3038026) Centromere Ab [Units/volume] in Serum

2.06

2.22

1.1

—

83.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

501

1.44

2.21

2.9

1.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.70

2.15

1.1

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.17

2.15

1.1

—

(3019977) pH of Arterial blood

2.31

2.15

2.6

3.5

7.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

167

1.75

2.12

1.1

—

(4024509)

2.06

2.11

1.7

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

233

1958

1.23

2.11

1.3

iu/ml

54.3

32.3

0.70

613

(3002619) Bacteria identified in Specimen by Culture

3.21

2.09

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

316

0.50

2.08

1.6

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.01

2.04

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

161

0.37

2.02

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

586

0.64

2.02

1.6

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.06

2.01

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.82

2.00

3.1

1.7

—

(40768800) Prostate Pathology biopsy report

322

0.52

1.96

1.1

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.99

1.95

1.0

1.1

—

70.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.56

1.94

3.2

2.2

—

(44806071)

3.76

1.93

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

155

0.38

1.89

1.5

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

156

0.38

1.89

1.5

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.16

1.88

8.6

2.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.54

1.84

1.2

1.4

—

(3014891) Appearance of Pleural fluid

3.54

1.84

2.0

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

3.54

1.84

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

4.18

1.82

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.34

1.74

1.0

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

132

1.75

1.74

1.2

1.5

—

(40757373) Influenza virus identified in Isolate

2.93

1.72

1.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

458

1.39

1.72

2.7

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.85

1.71

2.4

2.8

—

(3022621) pH of Urine by Test strip

731

1.31

1.67

5.6

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

150

1.68

1.64

1.9

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

150

1.68

1.64

1.9

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

135

1.71

1.63

3.9

4.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

155

1287

1.23

1.61

1.4

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

151

1.67

1.60

1.9

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

151

1.67

1.60

1.9

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.01

1.59

1.6

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.21

1.57

1.1

1.0

—

(3000012) Reticulocyte production index

2.11

1.55

1.4

1.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

153

1.64

1.53

1.9

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.34

1.52

1.8

2.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

574

1.32

1.51

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

203

0.49

1.48

1.3

1.5

—

(4306422)

187

1.56

1.46

1.1

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

125

1.69

1.44

1.7

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

2.73

1.43

2.7

3.5

u/l

944.5

3589.7

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

2.32

1.43

1.1

2.1

ug/l

85.7

63.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

363

1.39

1.42

1.3

1.6

mu/l

364.6

276.0

1.43

335

(3008295) Osmolality of Serum or Plasma

126

1.68

1.40

1.0

1.4

mosm/kgh2o

272.3

281.4

1.13

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.18

1.40

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.42

1.39

1.0

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

399

1.37

1.39

1.4

1.6

—

(40768795) Lymph node Pathology biopsy report

104

1.74

1.37

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

223

0.53

1.37

1.8

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.61

1.37

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.84

1.36

3.7

2.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.15

1.33

6.3

2.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

105

1.72

1.33

1.2

titre

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

192

1.52

1.32

1.0

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

850

8097

1.12

1.31

4.5

3.2

u/l

56.4

52.3

0.50

824

7580

(3024522) Salmonella sp identified in Specimen by Organism specific culture

153

1.58

1.29

2.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

210

1.49

1.28

1.8

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.73

1.27

1.1

—

(3033799) Differential panel - Peritoneal fluid

2.29

1.27

5.4

2.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.23

1.24

1.8

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

461

1.31

1.22

2.8

3.6

u/ml

1379.2

2994.4

0.30

390

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

116

1.65

1.21

1.4

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.73

1.21

1.4

1.5

promille

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.78

1.17

1.1

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

121

1017

1.21

1.16

3.5

2.9

ng/l

452.3

196.4

3.58

111

925

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1.71

1.11

1.3

mmol/l

11.5

13.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

268

1.39

1.11

1.7

1.4

e6/l

11.4

43.0

0.71

207

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

268

1.39

1.11

1.8

1.5

e6/l

641.0

840.2

0.10

214

(37021550) Renin [Units/volume] in Plasma --upright

2.26

1.10

1.0

1.3

mu/l

92.3

78.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.39

1.09

1.2

1.1

—

(3024263) Appearance of Synovial fluid

1.82

1.09

2.1

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

144

1.54

1.09

4.3

2.3

—

(3047181) Lactate [Moles/volume] in Blood

374

1.32

1.07

6.8

7.2

mmol/l

1.4

1.3

0.17

329

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.13

1.05

1.9

2.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.13

1.05

2.3

1.7

pmol/l

18.0

14.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.13

1.05

1.9

2.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

270

2972

0.89

1.01

2.6

3.0

ug/l

1.0

0.7

1.86

211

1940

(3013139) Helicobacter pylori Ag [Presence] in Stool

739

0.79

1.00

1.3

1.2

—

(3020650) Glucose [Presence] in Urine

2.00

1.00

1.3

1.2

—

(4146454)

135

0.52

0.98

3.6

2.6

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1140

11677

0.90

0.98

6.8

4.5

mmol/l

6.0

0.81

1085

10653

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.95

0.97

1.3

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.86

0.96

1.6

1.1

—

70.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.23

0.93

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

144

0.55

0.93

1.1

1.4

u/l

33.8

25.8

—

118

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

192

1.41

0.93

1.0

1.1

iu/ml

287.9

87.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

140

1223

1.16

0.90

3.0

4.3

ug/l

11.7

21.2

0.47

113

1006

(3048879) Bone marrow aspiration report

1.94

0.84

1.3

2.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1104

10772

1.10

0.83

5.0

4.5

mu/l

2.0

2.1

0.34

1050

9837

(4027681)

1.65

0.81

1.6

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

338

0.74

0.78

1.8

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.70

0.75

1.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

141

1.42

0.74

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

280

1.29

0.74

2.6

2.3

u/l

2674.9

2201.6

0.07

108

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.09

0.74

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

289

1.29

0.74

7.7

4.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.85

0.73

3.1

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.64

0.73

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

142

1590

0.88

0.73

1.7

1.9

1.7

1.5

1.38

122

1388

(3051387) C reactive protein [Mass/volume] in Capillary blood

265

0.71

0.73

3.9

3.7

mg/l

37.6

25.2

—

167

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.00

0.72

2.0

2.6

—

(3051593) INR in Capillary blood by Coagulation assay

1.61

0.72

9.1

16.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.75

0.71

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.93

0.70

1.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

292

1.27

0.70

1.3

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.85

0.68

2.2

2.8

—

(40768441) Liver Pathology biopsy report

102

1.48

0.67

1.3

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

119

1.43

0.67

1.3

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.79

0.66

1.8

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

154

1.37

0.65

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.73

0.64

2.8

1.6

—

(3023410) Appearance of Cerebral spinal fluid

129

1.40

0.63

1.7

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

252

1.28

0.63

1.7

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.60

0.61

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.57

0.60

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

122

1.40

0.60

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

122

1.40

0.60

1.7

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.59

0.0

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.51

0.58

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

312

1.22

0.54

1.6

1.2

mg/l

653.9

521.4

0.39

287

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

134

1474

0.90

0.54

6.6

4.4

32.4

31.7

0.34

117

1000

(3023383) Lactate [Moles/volume] in Pleural fluid

1.54

0.53

1.2

1.3

mmol/l

3.7

3.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

181

0.72

0.52

1.0

u/ml

9.3

7.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.62

0.52

1.0

1.8

nmol/l

12.3

19.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.39

0.50

1.1

1.2

u/l

100.8

452.5

—

(4281824)

101

1.39

0.49

1.4

1.2

—

(3000492) Spirometry study

109

1204

0.90

0.49

1.3

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

289

0.79

0.48

1.6

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

150

1381

1.10

0.47

1.6

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.59

0.45

1.2

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.37

0.43

1.1

1.6

umol/l

16.6

12.7

0.72

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

174

0.74

0.43

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.56

0.42

1.2

2.1

—

(3006653) Thiamine [Moles/volume] in Blood

1.43

0.41

1.4

1.3

nmol/l

132.2

145.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(4015189)

1.47

0.40

5.8

2.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

2.8

—

49.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

2.1

—

0.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

171

0.76

0.39

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.43

0.39

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.39

0.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.35

0.38

1.2

1.0

—

(3014271) Vancomycin [Susceptibility]

1.33

0.37

2.7

2.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

170

1.24

0.37

1.0

1.2

—

(40765096) Chromosome analysis panel by Banding

1.37

0.34

1.7

1.2

—

(4198724)

1.33

0.33

18.3

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

397

1.14

0.33

1.6

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.69

0.33

1.0

1.1

—

(40768793) Breast Pathology biopsy report

219

0.82

0.31

1.4

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

430

0.88

0.29

1.4

1.3

iu/l

25.0

28.8

0.28

364

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

130

1.23

0.28

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

103

1.26

0.28

1.5

2.4

umol/l

6.1

7.8

0.23

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.28

0.28

1.5

1.6

g/l

1.0

0.05

(1761868) Lipid panel - Serum or Plasma

454

4419

1.04

0.27

4.5

2.8

—

(3011288) Drugs identified in Urine by Screen method

290

0.86

0.27

6.2

3.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.23

0.27

2.3

2.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

187

1.18

0.26

2.7

3.1

u/ml

15.9

27.4

0.20

179

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.67

0.26

1.4

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

132

1.21

0.25

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

301

1.13

0.25

1.8

1.4

—

(3017732) Neutrophils [#/volume] in Blood

819

0.92

0.25

3.2

e9/l

4.5

4.1

0.61

636

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.25

0.24

1.4

1.3

u/ml

0.1

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.28

0.23

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

247

1.14

0.22

1.5

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.22

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

199

1914

1.05

0.22

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

135

1.19

0.21

2.4

2.3

mg/l

15.6

22.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

9.7

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.2

—

19.5

—

(3008898) HLA-B27 [Presence]

421

1.10

0.21

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

117

1.20

0.20

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.20

0.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

35.4

—

(4010399)

840

0.94

0.20

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.23

0.20

2.5

1.8

—

1688041.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

271

0.88

0.20

1.2

1.9

iu/l

2.1

5.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.15

0.19

5.0

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

154

0.84

0.19

1.7

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.22

0.17

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate

0.76

0.17

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.21

0.15

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

400

0.92

0.15

3.1

2.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.10

0.15

1.2

1.0

ng/l

409.9

281.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.10

0.15

1.2

1.0

ng/l

53.6

40.9

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.10

0.15

1.2

1.0

ng/l

471.2

594.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.79

0.14

2.1

2.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

314

1.08

0.14

1.7

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

515

5081

1.02

0.13

4.0

4.8

ug/l

2.6

0.05

473

4572

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

734

0.95

0.13

1.2

iu/ml

70.1

148.2

1.97

292

(4094501)

344

0.93

0.12

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

250

0.92

0.11

2.5

3.4

u/ml

23.5

1250.8

0.67

232

(3028300) Cannabinoids [Presence] in Urine

433

0.95

0.10

4.2

2.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.06

0.09

2.2

2.4

—

(3027008) Opiates [Presence] in Urine

431

0.95

0.09

4.1

2.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.83

0.08

9.8

6.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

104

1013

1.03

0.08

1.5

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

108

1053

1.03

0.08

1.5

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.08

0.08

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.08

0.08

1.6

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

109

1117

0.97

0.08

1.5

1.9

—

(3025130) Human papilloma virus identified in Specimen

1.12

0.07

1.8

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

428

0.96

0.07

4.1

2.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1106

11024

1.01

0.06

37.8

15.1

37.3

40.2

22.78

811

7966

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

514

1.03

0.05

1.6

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

110

0.91

0.05

1.4

—

(3027944) Amphetamines [Presence] in Urine

424

0.97

0.05

4.2

2.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

308

1.04

0.04

1.4

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

190

1.05

0.04

7.2

3.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

119

0.92

0.04

1.2

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

143

1447

0.99

0.03

16.5

7.1

—

(3005570) Glucose [Moles/volume] in Urine

129

0.93

0.03

1.5

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

149

0.94

0.03

1.1

1.2

—

(3010813) Leukocytes [#/volume] in Blood

1342

13435

0.99

0.03

57.9

20.6

e9/l

7.2

6.7

5.37

1318

13057

(3000963) Hemoglobin [Mass/volume] in Blood

1342

13435

0.99

0.03

58.2

20.7

g/l

127.0

137.0

74.37

1331

13229

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

192

1.04

0.02

1.5

1.1

—

9.6

—

(3026361) Erythrocytes [#/volume] in Blood

1342

13432

0.99

0.02

57.8

20.5

e12/l

4.2

4.5

56.98

1317

13058

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

409

0.98

0.02

1.5

1.8

—

(36660697) Celiac disease serology panel - Serum

870

1.01

0.02

1.3

1.2

—

(3035941) MCH [Entitic mass]

1342

13431

0.99

0.02

57.5

20.4

30.4

0.01

1331

13229

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

113

1.06

0.02

1.6

1.5

—

(3024731) MCV [Entitic volume]

1342

13430

0.99

0.01

57.6

20.5

92.2

91.0

15.19

1331

13230

(3003740) Influenza virus B Ag [Presence] in Specimen

193

1.04

0.01

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

193

1.04

0.01

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

114

1131

1.01

0.01

2.1

2.2

nmol/l

12.9

13.3

0.15

108

1011

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

192

0.99

0.00

1.7

1.6

—

(4034850)

388

1.01

0.00

14.6

9.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

331

1.00

0.00

4.8

2.3

—

(3007461) Platelets [#/volume] in Blood

1342

13422

1.00

0.00

57.9

20.5

e9/l

243.9

246.3

0.70

1320

13082

(1002224) Polysomnography panel

531

1.00

0.00

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

547

1.01

0.00

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

435

1.01

0.00

1.7

1.8

nmol/l

38.6

39.3

0.07

417

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.95

0.00

1.0

1.3

—

52.9

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

98.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.00

0.00

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

2.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

403.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1745.2

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

6.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.94

0.00

1.0

1.1

—

7.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(4211845)

1.02

0.00

5.4

3.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.5

—

2.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3001729) Color of Synovial fluid

0.00

0.0

1.3

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

7.6

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

181.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CHRONEPHROPATH and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_CHRONEPHROPATH	2.953 [2.51, 3.47]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.075

During the follow-up period (1.1.1998 — 31.12.2019), 650 out of 2317 females with N14_CHRONEPHROPATH died.

Males

Parameter	HR [95% CI]	p-value
N14_CHRONEPHROPATH	2.713 [2.41, 3.06]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 1145 out of 3091 males with N14_CHRONEPHROPATH died.

Mortality risk

Mortality risk for people of age

years, who have N14_CHRONEPHROPATH.

N-year risk	Females	Males
1	0.326%	0.519%
5	1.781%	3.095%
10	4.435%	7.277%
15	8.103%	13.566%
20	13.509%	22.233%

Relationships between endpoints

↥

Index endpoint: N14_CHRONEPHROPATH – Chronic nephritic syndrome

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Chronic nephritic syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints